Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer.

Liknande verk

• The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen
  av: Fox, S, et al.
  Publicerad: (2011)
• The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
  av: Fox, S, et al.
  Publicerad: (2011)
• Factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients
  av: Generali, D, et al.
  Publicerad: (2006)
• Principal factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients.
  av: Generali, D, et al.
  Publicerad: (2006)
• Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.
  av: Mele, T, et al.
  Publicerad: (2010)